ArticleTherapeutic advances in neurological disorders2017

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience.

Christiane Schneider-Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.